Committees

Subcommittees

BSGCT’s subcommittees plan and deliver focussed BSGCT activities.

Public and Patient Engagement

Mission: To engage the public, people affected and their families with gene and cell therapy through events and the PPE lecture series, designed to provide lay introductions to the rapidly developing world of gene and cell therapy.

​Members

  • Christos Georgiadis (Public Engagement Chair)
  • Rajvinder Karda (Public and Patient Engagement Chair)
  • Ivana Barbaric
  • Gerry McLachlan
  • Alan Parker
  • Mustafa Munye
  • Aniekan Etuk
  • Juan Francisco Antinao-Díaz
  • Sonam Gurung

Early Career Development & Collaboration

Mission: To engage with early career researchers in topics specifically relevant to career development and highlight opportunities for involvement in gene and cell therapy events.

​Members

  • Rebeca Gil Garzon (co-chair)
  • Ellie Chilcott (co-chair)
  • Riccardo Privolizzi (co-chair)
  • Amy Geard
  • Alicia Teijeira Crespo
  • Christos Georgiadis
  • Alan Parker

Communication & Promotion

Mission: The BSGCT Communications and Promotions sub-committee aims to provide members and non-members of our gene and cell therapy community with news of exciting and important advances and challenges in our field, through in-person and online events, blogs, newsletters and our social media.

​Members

  • Rebeca Gil Garzon (co-chair)
  • Carly Bliss (co-chair)
  • Giulia Massaro
  • Alex Baker
  • Joanne Ng
  • Sian Stafford
  • Beata Surmacz-Cordle

Equality, Diversity and Inclusion

Mission: The Equality, Diversity and Inclusion (EDI) Subcommittee will inform all activities of the society and reach out to enhance Global Majority membership.

​Members

  • Mustafa Munye (chair)
  • Ivana Barbaric
  • Annie Etuk
  • Rajvinder Karda
  • Stuart Nicklin
  • Alan Parker
  • Alessandra De Riva
  • Rafael Yáñez-Muñoz

Panels

BSGCT Partner Forum

Purpose

The BSGCT Partner Forum is an advisory body convened by the British Society for Gene and Cell Therapy (BSGCT) and has the following aims:

To provide a stage to allow relevant partner engagement with the BSGCT

  • To provide strategic advice to the BSGCT
  • To disseminate information on relevant BSGCT activities and initiatives
  • To identify and help overcome challenges to the development and adoption of ATMPs

​Terms of Reference

The Partner Forum has the remit to provide advice on and support:

  1. engagement between partners and BSGCT
  2. strategic interactions that will support partners’ and BSGCT’s activities
  3. co-ordinated activities between the BSGCT and partners
  4. discussion on developments in the sector that may require BSGCT input or action
  5. initiatives to enhance the delivery and scope of impact of the BSGCT
  6. the dissemination of information on BSGCT’s activities

The BSGCT has recently released a paper on training needs in the CGT industry (December 2023). Read here for more>

BSGCT Partner Forum as of 12/6/2024

Alex Baker, Accession Therapeutics and BSGCT
Ivana Barbaric, BSGCT General Secretary
Jacqueline Barry, CGT Catapult
Catriona Crombie, LifeArc
Alessandra de Riva, Advent Bio
Ben Doak, NHS England
Uta Griesenbach, Imperial College, previous BSGCT President Gunnel Hallden, Independent

Steve Howe, Resolution Therapeutics
Hareklea Markides, Innovate UK
Nick Meade, Genetic Alliance UK
James Miskin, Independent
Penny Morton, MRC UKRI
Mustafa Munye, Complement Therapeutics
Stuart Nicklin, BSGCT President-Elect
Rafael Yáñez, BSGCT President, Chair